Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
Phase 2 Recruiting
80 enrolled
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Phase 2 Recruiting
45 enrolled
METTSEO
Phase 1 Recruiting
15 enrolled
N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
Phase 2 Recruiting
45 enrolled
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Phase 1/2 Recruiting
139 enrolled
Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma
Phase 2 Recruiting
40 enrolled
TNT-HYPE
Phase 2 Recruiting
24 enrolled
Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma
Phase 2 Recruiting
37 enrolled
CIRSARC
Phase 3 Recruiting
351 enrolled
JS203 Combination Regimens in B-Cell Non-Hodgkin's Lymphoma
Phase 2 Recruiting
180 enrolled
Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma
Phase 2 Recruiting
49 enrolled
TORNADO
Phase 2 Recruiting
66 enrolled
O-ICE
Phase 2 Recruiting
25 enrolled
TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile Cancer
Phase 2 Recruiting
25 enrolled
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
Phase 3 Recruiting
5,000 enrolled
InPACT
Phase 3 Recruiting
200 enrolled
LBL 2018
Phase 3 Recruiting
683 enrolled
FaR-RMS
Phase 1/2 Recruiting
1,672 enrolled
Observation Study to Evaluate the Efficacy and Safety of Ifosfamide/Mesna in Patients With Metastatic Castration-resistant Prostate Cancer
Recruiting
60 enrolled
B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021
Phase 4 Recruiting
300 enrolled
The Efficacy of WVI in Patients With Localized Basal Ganglia Intracranial Germ Cell Tumors
Phase 2 Recruiting
150 enrolled